Background Although recent studies comparing various dosages and intervals of vitamin D supplementation have been published, it is yet to be elucidated whether there is an appropriate dose or interval to provide benefit regarding fracture risk. We aimed to assess the published evidence available to date regarding the putative beneficial effects of vitamin D supplements on fractures and falls according to various dosages and intervals.
Methods We performed a meta-analysis of randomized controlled studies reporting associations between vitamin D supplementation and the risks of fractures and falls in PubMed, EMBASE, and Cochrane library. Studies with supplements of ergocalciferol or calcitriol, those with a number of event ≤10, or those with a follow-up duration of less than 6 months were also excluded.
Results Thirty-two studies were included in the final analysis. Vitamin D supplementation with daily dose of 800 to 1,000 mg was associated with lower risks of osteoporotic fracture and fall (pooled relative risk [RR], 0.87; 95% confidence interval [CI], 0.78 to 0.97 and RR, 0.91; 95% CI, 0.85 to 0.98), while studies with <800 or >1,000 mg/day did not. Also, among intervals, daily administration of vitamin D was associated with the reduced risk of falls, while intermittent dose was not. Also, patients with vitamin D deficiency showed a significant risk reduction of falls after vitamin D supplementation.
Conclusion Daily vitamin D dose of 800 to 1,000 IU was the most probable way to reduce the fracture and fall risk. Further studies designed with various regimens and targeted vitamin D levels are required to elucidate the benefits of vitamin D supplements.
Citations
Citations to this article as recorded by
Ukrainian Consensus on Diagnosis and Management of Vitamin D Deficiency in Adults Nataliia Grygorieva, Mykola Tronko, Volodymir Kovalenko, Serhiy Komisarenko, Tetiana Tatarchuk, Ninel Dedukh, Mykola Veliky, Serhiy Strafun, Yulia Komisarenko, Andrii Kalashnikov, Valeria Orlenko, Volodymyr Pankiv, Oleg Shvets, Inna Gogunska, Svitlana Reg Nutrients.2024; 16(2): 270. CrossRef
Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 µg) of Vitamin D for Adults in the General Population Pawel Pludowski, William B. Grant, Spyridon N. Karras, Armin Zittermann, Stefan Pilz Nutrients.2024; 16(3): 391. CrossRef
Clinical Characteristics and Outcomes of Limb Fractures in Saudi Children Lamia Aldhbiban, Fai Alhoshan, Raghad Alomari, Shahad A Almatrafi, Yousef Alanazi, Samir Alsayegh, Haifa Y Alfaraidi, Ayman H Jawadi, Fahad N Aljuraibah Cureus.2024;[Epub] CrossRef
The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches Nikhil Gupta, Navjot Kanwar, Anchal Arora, Kavin Khatri, Abhinav Kanwal Clinical Rheumatology.2024; 43(5): 1421. CrossRef
The multi-faceted nature of age-associated osteoporosis A.E. Smit, O.C. Meijer, E.M. Winter Bone Reports.2024; 20: 101750. CrossRef
Vitamin D Deficiency in Patients With Low-Energy Hip Fractures in Accordance With the Mediterranean Paradox Christos Konstantinidis, Ourania Psoma, Christos Kotsias, Vasileios Panagiotopoulos , Sotiris Plakoutsis, Dimitrios Tsiampas, Dimitrios Vardakas, Dimitrios Giotis Cureus.2024;[Epub] CrossRef
Effect of vitamin D, calcium, or combined supplementation on fall prevention: a systematic review and updated network meta-analysis Long Tan, Ruiqian He, Xiaoxue Zheng BMC Geriatrics.2024;[Epub] CrossRef
Analysis of medication treatment for women with osteoporosis: A real-world retrospective study from Chinese tertiary grade A hospital Xiaolei Liu, Zhenling Zhu, Xianli Wang Bone Reports.2024; 21: 101778. CrossRef
New insights into dairy management and the prevention and treatment of osteoporosis: The shift from single nutrient to dairy matrix effects—A review Kaili Wang, Xu Zhao, Sijia Yang, Xiaoxi Qi, Aili Li, Wei Yu Comprehensive Reviews in Food Science and Food Safety.2024;[Epub] CrossRef
The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review Jan O. Aaseth, Trine Elisabeth Finnes, Merete Askim, Jan Alexander Nutrients.2024; 16(15): 2420. CrossRef
The role of anti-osteoporosis drugs in fall risk Gianpaolo Voltan, Nicola Veronese International Journal of Bone Fragility.2024; 4(1): 2. CrossRef
Pharmacologic or genetic interference with atrogene signaling protects against glucocorticoid-induced musculoskeletal and cardiac disease Amy Y. Sato, Meloney Cregor, Kevin McAndrews, Charles A. Schurman, Eric Schaible, Jennifer Shutter, Punit Vyas, Bhawana Adhikari, Monte S. Willis, Marjan Boerma, Tamara Alliston, Teresita Bellido JCI Insight.2024;[Epub] CrossRef
Vitamin D levels and bone mineral density: a prospective cross-sectional analysis of young orthopedic trauma patients at a rural United States trauma center Michael Booth, Kenneth Sabacinski, Colleen Watkins, Erin Butcho, Emilie Kramer, Lukas Meadows, Michelle A. Bramer Journal of Trauma and Injury.2024; 37(4): 276. CrossRef
Association of vitamin and/or nutritional supplements with fall among patients with diabetes: A prospective study based on ACCORD and UK Biobank Lingfang He, Tianqi Ma, Guogang Zhang, Xunjie Cheng, Yongping Bai Frontiers in Nutrition.2023;[Epub] CrossRef
Vitamin D and Calcium in Osteoporosis, and the Role of Bone Turnover Markers: A Narrative Review of Recent Data from RCTs Gavriela Voulgaridou, Sousana K. Papadopoulou, Paraskevi Detopoulou, Despoina Tsoumana, Constantinos Giaginis, Foivi S. Kondyli, Evgenia Lymperaki, Agathi Pritsa Diseases.2023; 11(1): 29. CrossRef
Recent advances in the identification of related factors and preventive strategies of hip fracture Yaohui Yu, Yudan Wang, Xiaoli Hou, Faming Tian Frontiers in Public Health.2023;[Epub] CrossRef
Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society? Sadao Yoshida, Ryo Shiraishi, Yuki Nakayama, Yasuko Taira Nutrients.2023; 15(13): 2991. CrossRef
Safety Profile of Vitamin D in Italy: An Analysis of Spontaneous Reports of Adverse Reactions Related to Drugs and Food Supplements Valentina Maggini, Giada Crescioli, Ilaria Ippoliti, Eugenia Gallo, Francesca Menniti-Ippolito, Adelaide Chiaravalloti, Vittorio Mascherini, Roberto Da Cas, Simona Potenza, Giulia Gritti, Maria Galiulo, Laura Sottosanti, Alfredo Vannacci, Niccolò Lombardi Journal of Clinical Medicine.2023; 12(14): 4726. CrossRef
Cholecalciferol Use Is Associated With a Decreased Risk of Incident Morphometric Vertebral Fractures in Acromegaly Sabrina Chiloiro, Stefano Frara, Irene Gagliardi, Antonio Bianchi, Antonella Giampietro, Margherita Medici, Agnese Allora, Luigi di Filippo, Maria Rosaria Ambrosio, Alfredo Pontecorvi, Maria Chiara Zatelli, Laura De Marinis, Andrea Giustina The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e58. CrossRef
Proceedings of the 2023 Santa Fe Bone Symposium: Progress and Controversies in the Management of Patients with Skeletal Diseases E. Michael Lewiecki, Teresita Bellido, John P. Bilezikian, Jacques P. Brown, Azeez Farooki, Christopher S. Kovacs, Brendan Lee, William D. Leslie, Michael R. McClung, Mark L. Prasarn, Deborah E. Sellmeyer Journal of Clinical Densitometry.2023; 26(4): 101432. CrossRef
Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients Menglin Pang, Lin Chen, Na Jiang, Mengmeng Jiang, Baofeng Wang, Lili Wang, Xiao-yan Jia Kidney and Blood Pressure Research.2023; 48(1): 231. CrossRef
Vitamin D for Clinical Diseases in Women: An Indispensable Factor in Medicine and Dentistry Dario Calafiore, Leonzio Fortunato, Mario Migliario Journal of Clinical Medicine.2022; 11(11): 3104. CrossRef
Malnutrition in Older Adults—Effect on Falls and Fractures: A Narrative Review Malgorzata Kupisz-Urbanska, Ewa Marcinowska-Suchowierska Nutrients.2022; 14(15): 3123. CrossRef
Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group Thierry Chevalley, Maria Luisa Brandi, Kevin D. Cashman, Etienne Cavalier, Nicholas C. Harvey, Stefania Maggi, Cyrus Cooper, Nasser Al-Daghri, Oliver Bock, Olivier Bruyère, Mario Miguel Rosa, Bernard Cortet, Alfonso J. Cruz-Jentoft, Antonio Cherubini, Bes Aging Clinical and Experimental Research.2022; 34(11): 2603. CrossRef
The Relationship of Osteoporosis with Menopause: Review of Article Hadeel Anwar Alsarraje, *Liqaa Khalel Alhyali International Journal of Research in Medical Sciences and Technology.2022; 14(01): 127. CrossRef
Background Since image-based fracture prediction models using deep learning are lacking, we aimed to develop an X-ray-based fracture prediction model using deep learning with longitudinal data.
Methods This study included 1,595 participants aged 50 to 75 years with at least two lumbosacral radiographs without baseline fractures from 2010 to 2015 at Seoul National University Hospital. Positive and negative cases were defined according to whether vertebral fractures developed during follow-up. The cases were divided into training (n=1,416) and test (n=179) sets. A convolutional neural network (CNN)-based prediction algorithm, DeepSurv, was trained with images and baseline clinical information (age, sex, body mass index, glucocorticoid use, and secondary osteoporosis). The concordance index (C-index) was used to compare performance between DeepSurv and the Fracture Risk Assessment Tool (FRAX) and Cox proportional hazard (CoxPH) models.
Results Of the total participants, 1,188 (74.4%) were women, and the mean age was 60.5 years. During a mean follow-up period of 40.7 months, vertebral fractures occurred in 7.5% (120/1,595) of participants. In the test set, when DeepSurv learned with images and clinical features, it showed higher performance than FRAX and CoxPH in terms of C-index values (DeepSurv, 0.612; 95% confidence interval [CI], 0.571 to 0.653; FRAX, 0.547; CoxPH, 0.594; 95% CI, 0.552 to 0.555). Notably, the DeepSurv method without clinical features had a higher C-index (0.614; 95% CI, 0.572 to 0.656) than that of FRAX in women.
Conclusion DeepSurv, a CNN-based prediction algorithm using baseline image and clinical information, outperformed the FRAX and CoxPH models in predicting osteoporotic fracture from spine radiographs in a longitudinal cohort.
Citations
Citations to this article as recorded by
Automated detection of vertebral fractures from X-ray images: A novel machine learning model and survey of the field Li-Wei Cheng, Hsin-Hung Chou, Yu-Xuan Cai, Kuo-Yuan Huang, Chin-Chiang Hsieh, Po-Lun Chu, I-Szu Cheng, Sun-Yuan Hsieh Neurocomputing.2024; 566: 126946. CrossRef
Application of radiomics model based on lumbar computed tomography in diagnosis of elderly osteoporosis Baisen Chen, Jiaming Cui, Chaochen Li, Pengjun Xu, Guanhua Xu, Jiawei Jiang, Pengfei Xue, Yuyu Sun, Zhiming Cui Journal of Orthopaedic Research.2024; 42(6): 1356. CrossRef
Machine Learning and Deep Learning in Spinal Injury: A Narrative Review of Algorithms in Diagnosis and Prognosis Satoshi Maki, Takeo Furuya, Masahiro Inoue, Yasuhiro Shiga, Kazuhide Inage, Yawara Eguchi, Sumihisa Orita, Seiji Ohtori Journal of Clinical Medicine.2024; 13(3): 705. CrossRef
A CT-based Deep Learning Model for Predicting Subsequent Fracture Risk in Patients with Hip Fracture Yisak Kim, Young-Gon Kim, Jung-Wee Park, Byung Woo Kim, Youmin Shin, Sung Hye Kong, Jung Hee Kim, Young-Kyun Lee, Sang Wan Kim, Chan Soo Shin Radiology.2024;[Epub] CrossRef
A Computed Tomography–Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study Sung Hye Kong, Wonwoo Cho, Sung Bae Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin Journal of Medical Internet Research.2024; 26: e48535. CrossRef
A Novel QCT-Based Deep Transfer Learning Approach for Predicting Stiffness Tensor of Trabecular Bone Cubes Pengwei Xiao, Tinghe Zhang, Yufei Huang, Xiaodu Wang IRBM.2024; 45(2): 100831. CrossRef
Deep learning in the radiologic diagnosis of osteoporosis: a literature review Yu He, Jiaxi Lin, Shiqi Zhu, Jinzhou Zhu, Zhonghua Xu Journal of International Medical Research.2024;[Epub] CrossRef
Pathological Priors Inspired Network for Vertebral Osteophytes Recognition Junzhang Huang, Xiongfeng Zhu, Ziyang Chen, Guoye Lin, Meiyan Huang, Qianjin Feng IEEE Transactions on Medical Imaging.2024; 43(7): 2522. CrossRef
Fully Automatic Deep Learning Model for Spine Refracture in Patients with OVCF: A Multi‐Center Study Xuetao Zhu, Dejian Liu, Lian Liu, Jingxuan Guo, Zedi Li, Yixiang Zhao, Tianhao Wu, Kaiwen Liu, Xinyu Liu, Xin Pan, Lei Qi, Yuanqiang Zhang, Lei Cheng, Bin Chen Orthopaedic Surgery.2024; 16(8): 2052. CrossRef
Artificial Intelligence in Spinal Imaging and Patient Care: A Review of Recent Advances Sungwon Lee, Joon-Yong Jung, Akaworn Mahatthanatrakul, Jin-Sung Kim Neurospine.2024; 21(2): 474. CrossRef
Machine learning value in the diagnosis of vertebral fractures: A systematic review and meta-analysis Yue Li, Zhuang Liang, Yingchun Li, Yang Cao, Hui Zhang, Bo Dong European Journal of Radiology.2024; 181: 111714. CrossRef
Development and reporting of artificial intelligence in osteoporosis management Guillaume Gatineau, Enisa Shevroja, Colin Vendrami, Elena Gonzalez-Rodriguez, William D Leslie, Olivier Lamy, Didier Hans Journal of Bone and Mineral Research.2024; 39(11): 1553. CrossRef
Artificial intelligence in risk prediction and diagnosis of vertebral fractures Srikar R. Namireddy, Saran S. Gill, Amaan Peerbhai, Abith G. Kamath, Daniele S. C. Ramsay, Hariharan Subbiah Ponniah, Ahmed Salih, Dragan Jankovic, Darius Kalasauskas, Jonathan Neuhoff, Andreas Kramer, Salvatore Russo, Santhosh G. Thavarajasingam Scientific Reports.2024;[Epub] CrossRef
Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer Min Wook Joo, Taehoon Ko, Min Seob Kim, Yong-Suk Lee, Seung Han Shin, Yang-Guk Chung, Hong Kwon Lee Clinical Orthopaedics & Related Research.2023; 481(11): 2247. CrossRef
Automated Opportunistic Trabecular Volumetric Bone Mineral Density Extraction Outperforms Manual Measurements for the Prediction of Vertebral Fractures in Routine CT Sophia S. Goller, Jon F. Rischewski, Thomas Liebig, Jens Ricke, Sebastian Siller, Vanessa F. Schmidt, Robert Stahl, Julian Kulozik, Thomas Baum, Jan S. Kirschke, Sarah C. Foreman, Alexandra S. Gersing Diagnostics.2023; 13(12): 2119. CrossRef
Machine learning‐based prediction of osteoporosis in postmenopausal women with clinical examined features: A quantitative clinical study Kainat A. Ullah, Faisal Rehman, Muhammad Anwar, Muhammad Faheem, Naveed Riaz Health Science Reports.2023;[Epub] CrossRef
Skeletal Fracture Detection with Deep Learning: A Comprehensive Review Zhihao Su, Afzan Adam, Mohammad Faidzul Nasrudin, Masri Ayob, Gauthamen Punganan Diagnostics.2023; 13(20): 3245. CrossRef
Deep learning system for automated detection of posterior ligamentous complex injury in patients with thoracolumbar fracture on MRI Sang Won Jo, Eun Kyung Khil, Kyoung Yeon Lee, Il Choi, Yu Sung Yoon, Jang Gyu Cha, Jae Hyeok Lee, Hyunggi Kim, Sun Yeop Lee Scientific Reports.2023;[Epub] CrossRef
Vertebra Segmentation Based Vertebral Compression Fracture Determination from Reconstructed Spine X-Ray Images Srinivasa Rao Gadu, Chandra Sekhar Potala International Journal of Electrical and Electronics Research.2023; 11(4): 1225. CrossRef
Computer Vision in Osteoporotic Vertebral Fracture Risk Prediction: A Systematic Review Anthony K. Allam, Adrish Anand, Alex R. Flores, Alexander E. Ropper Neurospine.2023; 20(4): 1112. CrossRef
A Meaningful Journey to Predict Fractures with Deep Learning Jeonghoon Ha Endocrinology and Metabolism.2022; 37(4): 617. CrossRef
New Horizons: Artificial Intelligence Tools for Managing Osteoporosis Hans Peter Dimai The Journal of Clinical Endocrinology & Metabolism.2022;[Epub] CrossRef
Antiresorptive-related osteonecrosis of the jaw (ARONJ) is a rare but serious adverse event of bisphosphonate or denosumab administration; it is associated with severe pain and a deteriorated quality of life. Since its first report in 2003, there have been many studies on its definition, epidemiology, pathophysiology, diagnosis, and treatment. Nevertheless, the epidemiology and mechanisms underlying this condition have not yet been fully delineated and several risk factors are known. Moreover, as there is no effective treatment currently available for osteonecrosis of the jaw, prevention is essential. Furthermore, close cooperation between prescribing physicians and dentists is important. The aim of this review was to provide up-to-date information regarding the risk factors and prevention of ARONJ from a physician’s perspective.
Citations
Citations to this article as recorded by
Risk factors for dental findings of the development of medication-related osteonecrosis of the jaw: Investigation of 3734 teeth in cancer patients receiving high dose antiresorptive agents Mitsunobu Otsuru, Yoshinari Fujiki, Sakiko Soutome, Norio Nakamura, Taro Miyoshi, Tomofumi Naruse, Mizuho Ohnuma, Yuka Hotokezaka, Satoshi Rokutanda, Masahiro Umeda Journal of Dental Sciences.2024; 19(1): 203. CrossRef
Editorial: Immunological processes in maxillofacial bone pathology Matthias Tröltzsch Frontiers in Immunology.2024;[Epub] CrossRef
Polysacharide of Agaricus blazei gel mitigates bone necrosis in model of the jaws related to bisphosphonate via Wnt signaling Vanessa Costa de Sousa, Fátima Regina Nunes Sousa, Raquel Felipe Vasconcelos, Gisele Angelino Barreto, Conceição S. Martins, Nilson Romero Dias, Sislana Costa, Maria Jennifer Chaves Bernardino, George de Almeida Silva, Nadine Linhares, Delane Gondim, Mirn Scientific Reports.2024;[Epub] CrossRef
Prevention of medication-related osteonecrosis of the jaw after tooth extraction by local administration of antibiotics and atelocollagen sponge: A preliminary study Natsumi Nakamura, Sakiko Soutome, Akira Imakiire, Satoshi Rokutanda, Seigo Ohba, Shunsuke Sawada, Yuka Kojima, Yuki Sakamoto, Yoshiko Yamamura, Madoka Funahara, Mitsunobu Otsuru, Masahiro Umeda Journal of Dental Sciences.2024;[Epub] CrossRef
A Systematic Review of Laser Photobiomodulation Dosimetry and Treatment Protocols in the Management of Medications-Related Osteonecrosis of the Jaws: A Rationalised Consensus for Future Randomised Controlled Clinical Trials Reem Hanna, Ioana Cristina Miron, Snehal Dalvi, Praveen Arany, René Jean Bensadoun, Stefano Benedicenti Pharmaceuticals.2024; 17(8): 1011. CrossRef
Perfil Odontológico dos Pacientes em Uso de Bisfosfonatos em um Hospital Oncológico Jade Fontenele Tagliabue, Lísia Daltro Borges Alves, Héliton Spíndola Antunes Revista Brasileira de Cancerologia.2024;[Epub] CrossRef
Position Paper on Medication-Related Osteonecrosis of the Jaw 2023 update -Key Points for Revision- Hiromitsu KISHIMOTO, Kuniyasu MORIDERA Japanese Journal of Oral and Maxillofacial Surgery.2024; 70(7): 278. CrossRef
Annual review of selected scientific literature: A report of the Committee on Scientific Investigation of the American Academy of Restorative Dentistry David R. Cagna, Terence E. Donovan, James R. McKee, James E. Metz, Riccardo Marzola, Kevin G. Murphy, Matthias Troeltzsch The Journal of Prosthetic Dentistry.2024; 132(6): 1133. CrossRef
Effectiveness of Local Use of Green Propolis-Loaded Lipid Nanoparticles as Adjuvant Therapy to Scaling and Root Planing in the Management of Periodontitis in Rats Treated with Zoledronate Glauco Rodrigues Carmo Silveira, Vinícius Franzão Ganzaroli, Luan Felipe Toro, Estevão Lopes-Pereira, Leandro Lemes da Costa, João Martins de Mello-Neto, Rogério Leone Buchaim, Valdir Gouveia Garcia, Leticia Helena Theodoro, José Maurício Sforcin, Priscyl International Journal of Molecular Sciences.2024; 25(22): 12443. CrossRef
Prevention of bone fractures for people with dementia 浩太郎 東 Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics.2024; 61(4): 436. CrossRef
When and how to stop denosumab therapy in a patient with osteoporosis Eirena L. Goulden, Rachel K. Crowley Clinical Endocrinology.2023; 98(5): 649. CrossRef
Clinical and Histopathological Aspects of MRONJ in Cancer Patients George Adrian Ciobanu, Laurențiu Mogoantă, Adrian Camen, Mihaela Ionescu, Daniel Vlad, Ionela Elisabeta Staicu, Cristina Maria Munteanu, Mircea Ionuț Gheorghiță, Răzvan Mercuț, Elena Claudia Sin, Sanda Mihaela Popescu Journal of Clinical Medicine.2023; 12(10): 3383. CrossRef
Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects Diana Nogueira, Inês Morais Caldas, Ricardo Jorge Dinis-Oliveira Archives of Oral Biology.2023; 155: 105792. CrossRef
Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid George Adrian Ciobanu, Laurențiu Mogoantă, Sanda Mihaela Popescu, Mihaela Ionescu, Cristina Maria Munteanu, Ionela Elisabeta Staicu, Răzvan Mercuț, Cristian Corneliu Georgescu, Monica Scrieciu, Daniel Vlad, Adrian Camen International Journal of Molecular Sciences.2023; 24(18): 14345. CrossRef
Analysis of the Degree of Information of Dental Surgeons about Antiresorptive Drugs According to the Time Since Graduation in Dentistry Flávia Godinho Costa Wanderley Rocha, Roberto Paulo Correia de Araújo Pesquisa Brasileira em Odontopediatria e Clínica Integrada.2023;[Epub] CrossRef
Safety and Efficacy of Pamidronate in Neonatal Hypercalcemia Caused by Subcutaneous Fat Necrosis: A Case Report Stefano Martinelli, Marco Pitea, Italo Francesco Gatelli, Tara Raouf, Graziano Barera, Ottavio Vitelli Frontiers in Pediatrics.2022;[Epub] CrossRef
Zoledronic acid for osteoporosis and associated low-energy fractures S. S. Rodionova, A. F. Kolondaev, A. N. Torgashin, I. A. Solomyannik Meditsinskiy sovet = Medical Council.2022; (21): 163. CrossRef
Parathyroidectomy is the treatment of choice for primary hyperparathyroidism when the clinical criteria are met. Although bilateral neck exploration is traditionally the standard method for surgery, minimally invasive parathyroidectomy (MIP), or focused parathyroidectomy, has been widely accepted with comparable curative outcomes. For successful MIP, accurate preoperative localization of parathyroid lesions is essential. However, no consensus exists on the optimal approach for localization. Currently, ultrasonography and technetium-99m-sestamibi–single photon emission computed tomography/computed tomography are widely accepted in most cases. However, exact localization cannot always be achieved, especially in cases with multiglandular disease, ectopic glands, recurrent disease, and normocalcemic primary hyperparathyroidism. Therefore, new modalities for preoperative localization have been developed and evaluated. Positron emission tomography/computed tomography and parathyroid venous sampling have demonstrated improvements in sensitivity and accuracy. Both anatomical and functional information can be obtained by combining these methods. As each approach has its advantages and disadvantages, the localization study should be deliberately chosen based on each patient’s clinical profile, costs, radiation exposure, and the availability of experienced experts. In this review, we summarize various methods for the localization of hyperfunctioning parathyroid tissues in primary hyperparathyroidism.
Citations
Citations to this article as recorded by
Diagnostic Ability and Correlation of Digital 11C-Methionine PET/CT in Primary Hyperparathyroidism with Inconclusive Standard Imaging Hee Beom Jeong, Yong-il Kim, Soyoon Yoon, Dong Yun Lee, Beom-Jun Kim, Seung Hun Lee, Jin-Sook Ryu Nuclear Medicine and Molecular Imaging.2025; 59(1): 72. CrossRef
Frequency and characteristics of ectopic parathyroid adenomas in a cohort of patients referred for 18F-fluorocholine PET/CT Friso M. van der Zant, Maurits Wondergem, Wouter A.M. Broos, Sergiy V. Lazarenko, Remco J.J. Knol Nuclear Medicine Communications.2025; 46(1): 89. CrossRef
Navigating diagnostic dilemmas: Localizing parathyroid adenoma in the presence of MIBI-avid thyroid nodules: A case report and literature review Zohreh Maghsoomi, Maryam Rafieemanesh, Atefeh kashanizadeh, Behnaz Boozari, Mohammad Reza Babaei, Neda Hatami, Mohammad E․ Khamseh, Mehran Arab-Ahmadi Radiology Case Reports.2025; 20(2): 1041. CrossRef
Correlation between parathyroid adenoma volume and perioperative outcomes in primary hyperparathyroidism: Does the size matter? Antonio Fiore, Sophie Eschlböck, Céline Carlen, Ioannis I. Lazaridis, Alexandros Lalos, Raoul Droeser, Tarik Delko, Alberto Posabella Updates in Surgery.2025;[Epub] CrossRef
Expression of the Calcium-Sensing Receptor on Normal and Abnormal Parathyroid and Thyroid Tissue Anne L. Worth, Mesrop Ayrapetyan, Susan J. Maygarden, Zibo Li, Zhanhong Wu, Chris B. Agala, Lawrence T. Kim Journal of Surgical Research.2024; 293: 618. CrossRef
Use of [18F]fluorocholine PET/CT in the detection of primary hyperparathyroidism in paediatrics: a case report Helena Martínez Sánchez, Francisca Moreno Macián, Sara León Cariñena, Carmen de Mingo Alemany, Lidia Blasco González, Raquel Sánchez Vañó Journal of Pediatric Endocrinology and Metabolism.2024; 37(6): 580. CrossRef
Primary hyperparathyroidism caused by a tiny mediastinal parathyroid adenoma with non-localising imaging studies Pedro Polastri Lima Peixoto, Daniella de Freitas Pereira Calheir Durço, Luiz Carlos Conti de Freitas BMJ Case Reports.2024; 17(7): e258728. CrossRef
Risk factors of transient and permanent hypoparathyroidism after thyroidectomy: a systematic review and meta-analysis Kang Ning, Yongchao Yu, Xinyi Zheng, Zhenyu Luo, Zan Jiao, Xinyu Liu, Yiyao Wang, Yarong Liang, Zhuoqi Zhang, Xianglin Ye, Weirui Wu, Jian Bu, Qiaorong Chen, Fuxiang Cheng, Lizhen Liu, Mingjie Jiang, Ankui Yang, Tong Wu, Zhongyuan Yang International Journal of Surgery.2024;[Epub] CrossRef
Bone Mineral Density and First Line Imaging with [18F]fluorocholine PET/CT in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism: Results from a Single Center Dagmar Schaffler-Schaden, Gregor Schweighofer-Zwink, Lukas Hehenwarter, Antje van der Zee-Neuen, Maria Flamm, Mohsen Beheshti, Christian Pirich Diagnostics.2024; 14(22): 2466. CrossRef
Parathyroid Miss—Does it Exist? A Critical Review Sunil Chumber, Gopal Puri, Reva S Sahu, Piyush Ranjan, Brijesh K Singh, Nishikant Damle Indian Journal of Endocrine Surgery and Research.2024; 19(2): 70. CrossRef
Localization in primary hyperparathyroidism Piyush Aggarwal, Vinisha Gunasekaran, Ashwani Sood, Bhagwant Rai Mittal Best Practice & Research Clinical Endocrinology & Metabolism.2024; : 101967. CrossRef
A Rare Case of Hyperfunctioning Lipoadenoma Presenting as a Cystic Pararthyroid Lesion Jinyoung Kim, Ohjoon Kwon, Tae-Jung Kim, So Lyung Jung, Eun Ji Han, Ki-Ho Song Journal of Bone Metabolism.2023; 30(2): 201. CrossRef
Role of 18F-Fluorocholine Positron Emission Tomography (PET)/Computed Tomography (CT) in Diagnosis of Elusive Parathyroid Adenoma Janan R Badier, Pokhraj P Suthar, Jagadeesh S Singh, Miral D Jhaveri Cureus.2023;[Epub] CrossRef
Pitfalls of DualTracer 99m-Technetium (Tc) Pertechnetate and Sestamibi Scintigraphy before Parathyroidectomy: Between Primary-Hyperparathyroidism-Associated Parathyroid Tumour and Ectopic Thyroid Tissue Mara Carsote, Mihaela Stanciu, Florina Ligia Popa, Oana-Claudia Sima, Eugenia Petrova, Anca-Pati Cucu, Claudiu Nistor Medicina.2023; 60(1): 15. CrossRef
Diagnostic Performance of Magnetic Resonance Imaging for Parathyroid Localization of Primary Hyperparathyroidism: A Systematic Review Max H. M. C. Scheepers, Zaid Al-Difaie, Lloyd Brandts, Andrea Peeters, Bjorn Winkens, Mahdi Al-Taher, Sanne M. E. Engelen, Tim Lubbers, Bas Havekes, Nicole D. Bouvy, Alida A. Postma Diagnostics.2023; 14(1): 25. CrossRef
Ye An Kim, Ji Won Yoon, Young Lee, Hyuk Jin Choi, Jae Won Yun, Eunsin Bae, Seung-Hyun Kwon, So Eun Ahn, Ah-Ra Do, Heejin Jin, Sungho Won, Do Joon Park, Chan Soo Shin, Je Hyun Seo
Endocrinol Metab. 2021;36(6):1189-1200. Published online December 2, 2021
Background Epidemiological data have shown that vitamin D deficiency is highly prevalent in Korea. Genetic factors influencing vitamin D deficiency in humans have been studied in Europe but are less known in East Asian countries, including Korea. We aimed to investigate the genetic factors related to vitamin D levels in Korean people using a genome-wide association study (GWAS).
Methods We included 12,642 subjects from three different genetic cohorts consisting of Korean participants. The GWAS was performed on 7,590 individuals using linear or logistic regression meta- and mega-analyses. After identifying significant single nucleotide polymorphisms (SNPs), we calculated heritability and performed replication and rare variant analyses. In addition, expression quantitative trait locus (eQTL) analysis for significant SNPs was performed.
Results rs12803256, in the actin epsilon 1, pseudogene (ACTE1P) gene, was identified as a novel polymorphism associated with vitamin D deficiency. SNPs, such as rs11723621 and rs7041, in the group-specific component gene (GC) and rs11023332 in the phosphodiesterase 3B (PDE3B) gene were significantly associated with vitamin D deficiency in both meta- and mega-analyses. The SNP heritability of the vitamin D concentration was estimated to be 7.23%. eQTL analysis for rs12803256 for the genes related to vitamin D metabolism, including glutamine-dependent NAD(+) synthetase (NADSYN1) and 7-dehydrocholesterol reductase (DHCR7), showed significantly different expression according to alleles.
Conclusion The genetic factors underlying vitamin D deficiency in Korea included polymorphisms in the GC, PDE3B, NADSYN1, and ACTE1P genes. The biological mechanism of a non-coding SNP (rs12803256) for DHCR7/NADSYN1 on vitamin D concentrations is unclear, warranting further investigations.
Citations
Citations to this article as recorded by
Implications of vitamin D deficiency in systemic inflammation and cardiovascular health Sanjay Kumar Dey, Shashank Kumar, Diksha Rani, Shashank Kumar Maurya, Pratibha Banerjee, Madhur Verma, Sabyasachi Senapati Critical Reviews in Food Science and Nutrition.2024; 64(28): 10438. CrossRef
Vitamin D-associated genetic variants in the Brazilian population: Investigating potential instruments for Mendelian randomization Caroline De Souza Silverio , Carolina Bonilla Biomédica.2024; 44(1): 45. CrossRef
Interaction between MARK3 (rs11623869), PLCB4 (rs6086746) and GEMIN2 (rs2277458) variants with bone mineral density and serum 25-hidroxivitamin D levels in Mexican Mestizo women Diana I. Aparicio-Bautista, Rogelio F. Jiménez-Ortega, Adriana Becerra-Cervera, Arnoldo Aquino-Gálvez, Valeria Ponce de León-Suárez, Leonora Casas-Ávila, Jorge Salmerón, Alberto Hidalgo-Bravo, Berenice Rivera-Paredez, Rafael Velázquez-Cruz Frontiers in Endocrinology.2024;[Epub] CrossRef
Micronutrient-Associated Single Nucleotide Polymorphism and Mental Health: A Mendelian Randomization Study Jingni Hui, Na Zhang, Meijuan Kang, Yifan Gou, Chen Liu, Ruixue Zhou, Ye Liu, Bingyi Wang, Panxing Shi, Shiqiang Cheng, Xuena Yang, Chuyu Pan, Feng Zhang Nutrients.2024; 16(13): 2042. CrossRef
Associations between Disc Hemorrhage and Primary Open-Angle Glaucoma Based on Genome-Wide Association and Mendelian Randomization Analyses Je Hyun Seo, Young Lee, Hyuk Jin Choi Biomedicines.2024; 12(10): 2253. CrossRef
Association between Vitamin D Deficiency and Clinical Parameters in Men and Women Aged 50 Years or Older: A Cross-Sectional Cohort Study Ji Hyun Lee, Ye An Kim, Young Sik Kim, Young Lee, Je Hyun Seo Nutrients.2023; 15(13): 3043. CrossRef
Single nucleotide polymorphisms in vitamin D binding protein and 25-hydroxylase genes affect vitamin D levels in adolescents of Arab ethnicity in Kuwait Abdur Rahman, Mohamed Abu-Farha, Arshad Channanath, Maha M. Hammad, Emil Anoop, Betty Chandy, Motasem Melhem, Fahd Al-Mulla, Thangavel Alphonse Thanaraj, Jehad Abubaker Frontiers in Endocrinology.2023;[Epub] CrossRef
Recent Information on Vitamin D Deficiency in an Adult Korean Population Visiting Local Clinics and Hospitals Rihwa Choi, Sung-Eun Cho, Sang Gon Lee, Eun Hee Lee Nutrients.2022; 14(9): 1978. CrossRef
The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies Massimiliano Berretta, Vincenzo Quagliariello, Alessia Bignucolo, Sergio Facchini, Nicola Maurea, Raffaele Di Francia, Francesco Fiorica, Saman Sharifi, Silvia Bressan, Sara N. Richter, Valentina Camozzi, Luca Rinaldi, Carla Scaroni, Monica Montopoli Antioxidants.2022; 11(6): 1090. CrossRef
A Genome-Wide Association Study of Genetic Variants of Apolipoprotein A1 Levels and Their Association with Vitamin D in Korean Cohorts Young Lee, Ji Won Yoon, Ye An Kim, Hyuk Jin Choi, Byung Woo Yoon, Je Hyun Seo Genes.2022; 13(9): 1553. CrossRef
Genetic Determinants of 25-Hydroxyvitamin D Concentrations and Their Relevance to Public Health Elina Hyppönen, Karani S. Vimaleswaran, Ang Zhou Nutrients.2022; 14(20): 4408. CrossRef
On the Centennial of Vitamin D—Vitamin D, Inflammation, and Autoimmune Thyroiditis: A Web of Links and Implications Leonidas H. Duntas, Krystallenia I. Alexandraki Nutrients.2022; 14(23): 5032. CrossRef
The genetic and epigenetic contributions to the development of nutritional rickets Innocent Ogunmwonyi, Adewale Adebajo, Jeremy Mark Wilkinson Frontiers in Endocrinology.2022;[Epub] CrossRef
Calcium & Bone Metabolism Big Data Articles (National Health Insurance Service Database)
Background In South Korea, women aged 66 years are eligible for complimentary bone mineral density (BMD) screening via the National Screening Program for Transitional Ages. We aimed to evaluate the 10-year fracture risk in women receiving BMD screening between January 2008 and December 2015.
Methods BMD was classified as normal (T-score ≥–1.0 standard deviation [SD]), osteopenia (T-score <–1.0 SD and >–2.5 SD), and osteoporosis (T score ≤–2.5 SD) from dual-energy X-ray absorptiometry. Follow-up continued from the screening date until a diagnosis for clinical fragility fracture (including sites of the vertebrae, hip, pelvis, clavicle, humerus, forearm, wrist, lower leg, and ankle), censored at the earliest date of trauma, death, or December 2017; fracture was ascertained using diagnostic codes from the National Health Insurance Service database. A multivariable Cox proportional hazard model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the risk of fracture in women with osteopenia or osteoporosis relative to women with normal BMD.
Results Among the 271,197 women screened, 44.0% had osteopenia and 35.2% had osteoporosis. The 10 year cumulative incidence of fragility fractures was 31.1%, 37.5%, and 44.3% in women with normal BMD, osteopenia, and osteoporosis, respectively. Fracture risk was higher in women with osteopenia (HR, 1.31; 95% CI, 1.28 to 1.34) and osteoporosis (HR, 1.68; 95% CI, 1.64 to 1.72) than in women with normal BMD.
Conclusion Women with osteopenia and women with osteoporosis, identified by the national BMD screening program, demonstrated a substantially elevated risk of fracture.
Citations
Citations to this article as recorded by
Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women S. Han, S. Kim, E.J. Yeh, H.S. Suh Osteoporosis International.2024; 35(2): 339. CrossRef
Duration of osteoporosis treatment to reduce the risk of subsequent osteoporotic fracture and all-cause mortality in elderly hip fracture patients in a Korean real-world study Soong Joon Lee, Minjoon Cho, Hojoon Lee, Hyuna Lim, Jae Hyup Lee Archives of Osteoporosis.2024;[Epub] CrossRef
Do Patients with Benign Paroxysmal Positional Vertigo Have a Higher Prevalence of Osteoporosis? A Systematic Review and Meta-Analysis Chul-Ho Kim, Keunho Kim, Yeonjoo Choi Journal of Personalized Medicine.2024; 14(3): 303. CrossRef
Prediction models incorporating second metacarpal cortical index for osteoporosis in rheumatoid arthritis: Externally validated machine learning models developed using data from the KURAMA cohort Ryohei Saito, Takayuki Fujii, Koichi Murata, Akira Onishi, Kosaku Murakami, Masao Tanaka, Koichiro Ohmura, Tadashi Yasuda, Akio Morinobu, Shuichi Matsuda International Journal of Rheumatic Diseases.2024;[Epub] CrossRef
Concentration and genetic regulation of sex hormone binding globulin and fracture risk in older women Yuanyuan Wang, Chenglong Yu, Rakibul M. Islam, Sultana Monira Hussain, Anna L. Barker, Paul Lacaze, John J. McNeil, Susan R. Davis Climacteric.2024; : 1. CrossRef
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee Endocrinology and Metabolism.2023; 38(1): 10. CrossRef
Chronic airway disease as a major risk factor for fractures in osteopenic women: Nationwide cohort study Sung Hye Kong, Ae Jeong Jo, Chan Mi Park, Kyun Ik Park, Ji Eun Yun, Jung Hee Kim Frontiers in Endocrinology.2023;[Epub] CrossRef
Biomimetic Porous Magnesium Alloy Scaffolds Promote the Repair of Osteoporotic Bone Defects in Rats through Activating the Wnt/β-Catenin Signaling Pathway Yuanchao Zhu, Gaozhi Jia, Yifei Yang, Jian Weng, Su Liu, Mengwei Zhang, Geng Zhang, Haotian Qin, Yixiao Chen, Qi Yang, Guangyin Yuan, Fei Yu, Hui Zeng ACS Biomaterials Science & Engineering.2023; 9(6): 3435. CrossRef
Correlation between bone mineral density and bone metabolic markers in postmenopausal women with osteoporotic fractures at different C-terminal telopeptide of type 1 collagen levels: a retrospective analysis study Xiaonan Zhu, Lin Chen, Ling Pan, Yuexi Zeng, Qiang Fu, Yanbin Liu, Yongde Peng, Yufan Wang, Li You Menopause.2023; 30(11): 1139. CrossRef
Age-Dependent Association of Height Loss with Incident Fracture Risk in Postmenopausal Korean Women Chaewon Lee, Hye-Sun Park, Yumie Rhee, Namki Hong Endocrinology and Metabolism.2023; 38(6): 669. CrossRef
A Meaningful Journey to Predict Fractures with Deep Learning Jeonghoon Ha Endocrinology and Metabolism.2022; 37(4): 617. CrossRef
The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia Kyung Wook Kim, Young Il Kim, Ki-Choul Kim Journal of Bone Metabolism.2022; 29(3): 185. CrossRef
Correlation of Psoas Muscle Index with Fragility Vertebral Fracture: A Retrospective Cross-Sectional Study of Middle-Aged and Elderly Women Yihui Zhang, Yilihamu Dilixiati, Wei Jiang, Xiufeng Cao, Yuanyuan Chen, Hui Guo, Christian-Heinz Anderwald International Journal of Endocrinology.2022; 2022: 1. CrossRef
In this unprecedented era of the overwhelming volume of medical data, machine learning can be a promising tool that may shed light on an individualized approach and a better understanding of the disease in the field of osteoporosis research, similar to that in other research fields. This review aimed to provide an overview of the latest studies using machine learning to address issues, mainly focusing on osteoporosis and fractures. Machine learning models for diagnosing and classifying osteoporosis and detecting fractures from images have shown promising performance. Fracture risk prediction is another promising field of research, and studies are being conducted using various data sources. However, these approaches may be biased due to the nature of the techniques or the quality of the data. Therefore, more studies based on the proposed guidelines are needed to improve the technical feasibility and generalizability of artificial intelligence algorithms.
Citations
Citations to this article as recorded by
Predicting postoperative outcomes in lumbar spinal fusion: development of a machine learning model Lukas Schönnagel, Thomas Caffard, Tu-Lan Vu-Han, Jiaqi Zhu, Isaac Nathoo, Kyle Finos, Gaston Camino-Willhuber, Soji Tani, Ali. E. Guven, Henryk Haffer, Maximilian Muellner, Artine Arzani, Erika Chiapparelli, Krizia Amoroso, Jennifer Shue, Roland Duculan, The Spine Journal.2024; 24(2): 239. CrossRef
A CT-based Deep Learning Model for Predicting Subsequent Fracture Risk in Patients with Hip Fracture Yisak Kim, Young-Gon Kim, Jung-Wee Park, Byung Woo Kim, Youmin Shin, Sung Hye Kong, Jung Hee Kim, Young-Kyun Lee, Sang Wan Kim, Chan Soo Shin Radiology.2024;[Epub] CrossRef
Applying machine learning classification techniques for disease diagnosis from medical imaging data using Transformer based Attention Guided CNN (TAGCNN) Saleh Alyahyan Multimedia Tools and Applications.2024; 83(29): 72861. CrossRef
Machine Learning in Assessing Canine Bone Fracture Risk: A Retrospective and Predictive Approach Ernest Kostenko, Jakov Šengaut, Algirdas Maknickas Applied Sciences.2024; 14(11): 4867. CrossRef
A Computed Tomography–Based Fracture Prediction Model With Images of Vertebral Bones and Muscles by Employing Deep Learning: Development and Validation Study Sung Hye Kong, Wonwoo Cho, Sung Bae Park, Jaegul Choo, Jung Hee Kim, Sang Wan Kim, Chan Soo Shin Journal of Medical Internet Research.2024; 26: e48535. CrossRef
Sensing the future: A review on emerging technologies for assessing and monitoring bone health Amruta Naik, Anup A. Kale, Jyutika M. Rajwade Biomaterials Advances.2024; 165: 214008. CrossRef
Associations between longitudinal fluoride intakes from birth to age 23 and multi‐row detector computed tomography bone densitometry outcomes at age 23 Gurjot Kaur Bhatia, Steven M. Levy, John J. Warren, Oscar A. Rysavy, Punam K. Saha, Xiaoliu Zhang, Erliang Zeng Journal of Public Health Dentistry.2024; 84(4): 428. CrossRef
Artificial Intelligence Applications for Imaging Metabolic Bone Diseases Amanda Isaac, Asli Irmak Akdogan, Danoob Dalili, Nuran Saber, David Drobny, Giuseppe Guglielmi, Marc Modat, Alberto Bazzocchi Seminars in Musculoskeletal Radiology.2024; 28(05): 610. CrossRef
From Genomics to Metabolomics: Molecular Insights into Osteoporosis for Enhanced Diagnostic and Therapeutic Approaches Qingmei Li, Jihan Wang, Congzhe Zhao Biomedicines.2024; 12(10): 2389. CrossRef
Development and validation of common data model-based fracture prediction model using machine learning algorithm Sung Hye Kong, Sihyeon Kim, Yisak Kim, Jung Hee Kim, Kwangsoo Kim, Chan Soo Shin Osteoporosis International.2023; 34(8): 1437. CrossRef
Machine learning algorithms for predicting the risk of fracture in patients with diabetes in China Sijia Chu, Aijun Jiang, Lyuzhou Chen, Xi Zhang, Xiurong Shen, Wan Zhou, Shandong Ye, Chao Chen, Shilu Zhang, Li Zhang, Yang Chen, Ya Miao, Wei Wang Heliyon.2023; 9(7): e18186. CrossRef
Leveraging Artificial Intelligence and Machine Learning in Regenerative Orthopedics: A Paradigm Shift in Patient Care Madhan Jeyaraman, Harish V K Ratna, Naveen Jeyaraman, Aakaash Venkatesan, Swaminathan Ramasubramanian , Sankalp Yadav Cureus.2023;[Epub] CrossRef
Quality use of artificial intelligence in medical imaging: What do radiologists need to know? Stacy K Goergen, Helen ML Frazer, Sandeep Reddy Journal of Medical Imaging and Radiation Oncology.2022; 66(2): 225. CrossRef
Since our discovery in 2006 that acromegaly is associated with an increased risk of vertebral fractures, many authors have confirmed this finding in both cross-sectional and prospective studies. Due to the high epidemiological and clinical impact of this newly discovered comorbidity of acromegaly, this topic has progressively become more important and prominent over the years, and the pertinent literature has been enriched by new findings on the pathophysiology and treatment. The aim of this narrative review was to discuss these novel findings, integrating them with the seminal observations, in order to give the reader an updated view of how the field of acromegaly and bone is developing, from strong clinical observations to a mechanistic understanding and possible prevention and treatment.
Citations
Citations to this article as recorded by
Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach Alessandro Giustina, Andrea Giustina Reviews in Endocrine and Metabolic Disorders.2025; 26(1): 1. CrossRef
New insights into the vitamin D/PTH axis in endocrine-driven metabolic bone diseases Luigi di Filippo, John P. Bilezikian, Ernesto Canalis, Umberto Terenzi, Andrea Giustina Endocrine.2024; 85(3): 1007. CrossRef
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience Sabrina Chiloiro, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Liverana Lauretti, Alessandro Olivi, Laura De Marinis, Alfredo Pontecorvi, Francesco Doglietto, Antonio Bianchi Pituitary.2024; 27(3): 303. CrossRef
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE) Andrea Giustina, M. M. Uygur, S. Frara, A. Barkan, N. R. Biermasz, P. Chanson, P. Freda, M. Gadelha, L. Haberbosch, U. B. Kaiser, S. Lamberts, E. Laws, L. B. Nachtigall, V. Popovic, M. Reincke, A. J. van der Lely, J. A. H. Wass, S. Melmed, F. F. Casanueva Pituitary.2024; 27(4): 381. CrossRef
Vertebral fractures in patients with non-functioning pituitary adenomas - a new frontier? Nicholas A. Tritos Pituitary.2024; 27(4): 311. CrossRef
Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report Tongxin Xiao, Xinxin Mao, Ou Wang, Yong Yao, Kan Deng, Huijuan Zhu, Lian Duan BMC Endocrine Disorders.2024;[Epub] CrossRef
Skeletal fragility in pituitary disease: how can we predict fracture risk? Fabio Bioletto, Alessandro Maria Berton, Marco Barale, Luigi Simone Aversa, Lorenzo Sauro, Michela Presti, Francesca Mocellini, Noemi Sagone, Ezio Ghigo, Massimo Procopio, Silvia Grottoli Pituitary.2024; 27(6): 789. CrossRef
Vitamin D in pituitary driven osteopathies Sabrina Chiloiro, Flavia Costanza, Elena Riccardi, Antonella Giampietro, Laura De Marinis, Antonio Bianchi, Alfredo Pontecorvi, Andrea Giustina Pituitary.2024; 27(6): 847. CrossRef
GH receptor polymorphisms guide second-line therapies to prevent acromegaly skeletal fragility: preliminary results of a pilot study Sabrina Chiloiro, Flavia Costanza, Antonella Giampietro, Amato Infante, Pier Paolo Mattogno, Flavia Angelini, Consolato Gullì, Liverana Lauretti, Mario Rigante, Alessandro Olivi, Laura De Marinis, Francesco Doglietto, Antonio Bianchi, Alfredo Pontecorvi Frontiers in Endocrinology.2024;[Epub] CrossRef
Growth hormone and bone: a basic perspective Simona Bolamperti, Isabella Villa, Luigi di Filippo Pituitary.2024; 27(6): 745. CrossRef
Approach to the patient with controlled acromegaly and acromegalic arthropathy: clinical diagnosis and management Iris C. M. Pelsma, Herman M. Kroon, Cornelie D. Andela, Enrike M. J. van der Linden, Margreet Kloppenburg, Nienke R. Biermasz, Kim M. J. A. Claessen Pituitary.2024; 27(6): 824. CrossRef
Modern approach to bone comorbidity in prolactinoma Meliha Melin Uygur, Sara Menotti, Simona Santoro, Andrea Giustina Pituitary.2024; 27(6): 802. CrossRef
Novel approach to bone comorbidity in resistant acromegaly Stefano Frara, Matteo Acanfora, Vincenzo Franzese, Maria Luisa Brandi, Marco Losa, Andrea Giustina Pituitary.2024; 27(6): 813. CrossRef
Denosumab, which has been approved for the treatment of osteoporosis since 2010, is a fully humanised monoclonal antibody against a cytokine, receptor activator of nuclear factor kappa B ligand (RANKL), involved in bone resorption. Continued use of denosumab results in a potent and sustained decrease in bone turnover, an increase in bone mineral density (BMD), and a reduction in vertebral and hip fractures. The anti-resorptive effects of denosumab are reversible upon cessation, and this reversal is accompanied by a transient marked increase in bone turnover that is associated with bone loss, and of concern, an increased risk of multiple vertebral fractures. In this review, we outline the effects of denosumab withdrawal on bone turnover markers, BMD, histomorphometry, and fracture risk. We provide an update on recent clinical trials that sought to answer how clinicians can transition away from denosumab safely with follow-on therapy to mitigate bone loss and summarise the recommendations of various international guidelines.
Citations
Citations to this article as recorded by
Multiple vertebral fractures after antiosteoporotic medications discontinuation: A comparative study to evaluate the potential rebound effect of denosumab Mar Martín-Pérez, Beatriz Sánchez-Delgado, Patricia García-Poza, Sergio López-Álvarez, Elisa Martín-Merino Bone.2025; 190: 117325. CrossRef
Naïve Bayes is an interpretable and predictive machine learning algorithm in predicting osteoporotic hip fracture in-hospital mortality compared to other machine learning algorithms Jo-Wai Douglas Wang, Mathew V. Kiang PLOS Digital Health.2025; 4(1): e0000529. CrossRef
Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes Carmelinda Ruggiero, Carla Caffarelli, Valeria Calsolaro, Laura Tafaro, Francesca Riuzzi, Valentina Bubba, Nicola Napoli, Marika Ferracci, Patrizia Mecocci, Andrea Giusti, Giuseppe Rinonapoli Drugs & Aging.2025; 42(1): 21. CrossRef
Denosumab: A Useful Addition to the Armamentarium for the Management of Male Osteoporosis Jijith Krishnan, Sham Santhanam, Bhuwan Singh, Salim Patel, Divya G Bhojwani, Sameer Muchhala Cureus.2024;[Epub] CrossRef
Enhancing Treatment Success in Osteoporosis: Optimising the Use of Teriparatide
Denosumab combined with chemotherapy followed by anlotinib in the treatment of multiple metastases of malignant peripheral nerve sheath tumor: a case report and literature review Qian Chen, Haocheng Cui, Kai Zheng, Ming Xu, Xiuchun Yu Frontiers in Oncology.2024;[Epub] CrossRef
The use of denosumab in osteoporosis – an update on efficacy and drug safety Dima L. Diab, Nelson B. Watts Expert Opinion on Drug Safety.2024; 23(9): 1069. CrossRef
Denosumab in Osteoporosis: Predicting Long-Term Efficacy beyond 10 Years Jeongmin Lee, Youn-Ju Lee, Jeonghoon Ha Journal of Bone Metabolism.2024; 31(3): 246. CrossRef
Osteoporose – Definition, Risikoerfassung, Diagnose, Prävention und Therapie (Update 2024) Hans Peter Dimai, Christian Muschitz, Karin Amrein, Rosemarie Bauer, Daniel Cejka, Rudolf Wolfgang Gasser, Reinhard Gruber, Judith Haschka, Timothy Hasenöhrl, Franz Kainberger, Katharina Kerschan-Schindl, Roland Kocijan, Jürgen König, Norbert Kroißenbrunn Wiener klinische Wochenschrift.2024; 136(S16): 599. CrossRef
Denosumab stimulates spermatogenesis in infertile men with preserved Sertoli cell capacity Christine H. Andreassen, Rune Holt, Li Juel Mortensen, Nadia Krarup Knudsen, John E. Nielsen, Nadia Nicholine Poulsen, Sam K. Yahyavi, Ida M. Boisen, Zhihui Cui, Luisina Ongaro, Jasmin P. Hjerresen, Birgitte G. Toft, Thomas Hasselager, Niklas R. Jørgensen Cell Reports Medicine.2024; 5(10): 101783. CrossRef
Loss of lower extremity bone mineral density 1 year after denosumab is discontinued in persons with subacute spinal cord injury Christopher M. Cirnigliaro, Michael F. La Fountaine, J. Scott Parrott, Steven C. Kirshblum, Susan J. Sauer, Sue A. Shapses, Isa A. McClure, William A. Bauman Osteoporosis International.2023; 34(4): 741. CrossRef
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek Endocrinology and Metabolism.2023; 38(2): 260. CrossRef
Maintenance of skeletal integrity requires the coordinated activity of multinucleated bone-resorbing osteoclasts and bone-forming osteoblasts. Osteoclasts form resorption lacunae on bone surfaces in response to cytokines by fusion of precursor cells. Osteoblasts are derived from mesenchymal precursors and lay down new bone in resorption lacunae during bone remodeling. Nuclear factorkappa B (NF-κB) signaling regulates osteoclast and osteoblast formation and is activated in osteoclast precursors in response to the essential osteoclastogenic cytokine, receptor activator of NF-κB ligand (RANKL), which can also control osteoblast formation through RANK-RANKL reverse signaling in osteoblast precursors. RANKL and some pro-inflammatory cytokines, including tumor necrosis factor (TNF), activate NF-κB signaling to positively regulate osteoclast formation and functions. However, these cytokines also limit osteoclast and osteoblast formation through NF-κB signaling molecules, including TNF receptor-associated factors (TRAFs). TRAF6 mediates RANKL-induced osteoclast formation through canonical NF-κB signaling. In contrast, TRAF3 limits RANKL- and TNF-induced osteoclast formation, and it restricts transforming growth factor β (TGFβ)-induced inhibition of osteoblast formation in young and adult mice. During aging, neutrophils expressing TGFβ and C-C chemokine receptor type 5 (CCR5) increase in bone marrow of mice in response to increased NF-κB-induced CC motif chemokine ligand 5 (CCL5) expression by mesenchymal progenitor cells and injection of these neutrophils into young mice decreased bone mass. TGFβ causes degradation of TRAF3, resulting in decreased glycogen synthase kinase-3β/β-catenin-mediated osteoblast formation and age-related osteoporosis in mice. The CCR5 inhibitor, maraviroc, prevented accumulation of TGFβ+/CCR5+ neutrophils in bone marrow and increased bone mass by inhibiting bone resorption and increasing bone formation in aged mice. This paper updates current understanding of how NF-κB signaling is involved in the positive and negative regulation of cytokine-mediated osteoclast and osteoblast formation and activation with a focus on the role of TRAF3 signaling, which can be targeted therapeutically to enhance bone mass.
Citations
Citations to this article as recorded by
The Role of Rosavin in the Pathophysiology of Bone Metabolism Piotr Wojdasiewicz, Paweł Turczyn, Anna Lach-Gruba, Łukasz A. Poniatowski, Daryush Purrahman, Mohammad-Reza Mahmoudian-Sani, Dariusz Szukiewicz International Journal of Molecular Sciences.2024; 25(4): 2117. CrossRef
The role of monocyte/macrophage chemokines in pathogenesis of osteoarthritis: A review Hao Luo, Linfeng Li, Song Han, Tao Liu International Journal of Immunogenetics.2024; 51(3): 130. CrossRef
The effect of low-level laser therapy on osteoclast differentiation: Clinical implications for tooth movement and bone density Chun-Yi Huang, Huynh Hoai Thuong Le, Hsiao-Chi Tsai, Chih-Hsin Tang, Jian-Hong Yu Journal of Dental Sciences.2024; 19(3): 1452. CrossRef
Anti-arthritic and immunomodulatory efficacy of Micromeria biflora Benth extract and its fractions in rats by restoring oxidative stress, metalloproteinases, pro-inflammatory and anti-inflammatory cytokines network Fakhria A. Al-Joufi, Ambreen Malik Uttra, Sumera Qasim, Urooj Iqbal, Nabeela Tabassum Sial, Noura M. Alhumaid Inflammopharmacology.2024; 32(4): 2477. CrossRef
Evaluation of Immunohistochemical Biomarkers in Diabetic Wistar Rats with Periodontal Disease Ioana Scrobota, Ioan Andrei Tig, Andrea Olivia Marcu, Georgiana Ioana Potra Cicalau, Liliana Sachelarie, Gilda Iova Journal of Personalized Medicine.2024; 14(5): 527. CrossRef
The role of magnesium in the pathogenesis of osteoporosis Lin Liu, Pan Luo, Pengfei Wen, Peng Xu Frontiers in Endocrinology.2024;[Epub] CrossRef
Current Perspectives of Protein in Bone Tissue Engineering: Bone Structure, Ideal Scaffolds, Fabrication Techniques, Applications, Scopes, and Future Advances Muhammad Umar Aslam Khan, Muhammad Azhar Aslam, Mohd Faizal Bin Abdullah, Goran M. Stojanović ACS Applied Bio Materials.2024; 7(8): 5082. CrossRef
Effect of recombinant human bone morphogenetic protein-2 and osteoprotegerin-Fc in MC3T3-E1 cells: beyond challenges to success Chang Hoon Lee Journal of Rheumatic Diseases.2024; 31(3): 133. CrossRef
Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells Yerin Yu, Somin Lee, Minsung Bock, Seong Bae An, Hae Eun Shin, Jong Seop Rim, Jun-oh Kwon, Kwang-Sook Park, Inbo Han International Journal of Molecular Sciences.2024; 25(15): 8174. CrossRef
Identification of novel RANKL inhibitors through in silico analysis Yingying Jiang, Xiaogang Luo, Zhanpeng Zheng, Shun Wen, Hongwei Gao, Cheng Xu, Min Jiang, Siyuan Wang Bioorganic Chemistry.2024; 153: 107826. CrossRef
Genetic Deficiency of the Long Pentraxin 3 Affects Osteogenesis and Osteoclastogenesis in Homeostatic and Inflammatory Conditions Valentina Granata, Dario Strina, Maria Lucia Schiavone, Barbara Bottazzi, Alberto Mantovani, Antonio Inforzato, Cristina Sobacchi International Journal of Molecular Sciences.2023; 24(23): 16648. CrossRef
Seong Hee Ahn, Hee-Won Jung, Eunju Lee, Ji Yeon Baek, Il-Young Jang, So Jeong Park, Jin Young Lee, Eunah Choi, Yun Sun Lee, Seongbin Hong, Beom-Jun Kim
Endocrinol Metab. 2022;37(3):487-496. Published online May 27, 2022
Background Although muscles and bones interact with each other through various secretory factors, the role of sclerostin, an osteocyte-secreted factor, on muscle metabolism has not been well studied. We investigated the levels of serum sclerostin in Korean older adults with sarcopenia.
Methods Blood samples were collected from 129 participants who underwent evaluation of muscle mass and function in an outpatient geriatric clinic of a teaching hospital. Sarcopenia and related parameters were determined using cutoff values for the Asian population. Serum sclerostin levels were measured using an enzyme-linked immunosorbent assay.
Results The mean age of the participants was 69.6 years, and 20 participants (15.5%) were classified as having sarcopenia. After adjusting for age, sex, and body mass index, serum sclerostin levels were significantly lower in participants with sarcopenia, low muscle mass, or weak muscle strength (P=0.003 to 0.045). Serum sclerostin levels were positively associated with skeletal muscle index and grip strength after adjusting for confounders (P=0.001 and P=0.003), whereas sarcopenic phenotype score showed a negative association (P=0.006). These increases in muscle mass and strength were also dose dependent as serum sclerostin levels increased (P for trends=0.003 and P for trends=0.015). Higher serum sclerostin levels were associated with lower odds ratio (ORs) for sarcopenia, low muscle mass, and weak muscle strength after adjusting for confounders (OR, 0.27 to 0.50; P<0.001 to 0.025).
Conclusion Higher serum sclerostin levels were associated with a lower risk of sarcopenia, low muscle mass, and weak muscle strength in Korean older adults.
Citations
Citations to this article as recorded by
Mechanism and physical activities in bone-skeletal muscle crosstalk Zhonghan Zhao, Kai Yan, Qiao Guan, Qiang Guo, Can Zhao Frontiers in Endocrinology.2024;[Epub] CrossRef
Musculoskeletal disorders and coronary artery disease —promising molecular markers: literature review Viktoria N. Karetnikova, Anastasiya G. Neeshpapa, Evgenia I. Carpova, Olga L. Barbarash CardioSomatics.2024; 15(1): 55. CrossRef
Differences in Type 2 Fiber Composition in the Vastus Lateralis and Gluteus Maximus of Patients with Hip Fractures Jingwen Tian, Minchul Song, Kyu Jeong Cho, Ho Yeop Lee, Sang Hyeon Ju, Jung Ryul Lim, Ha Thi Nga, Thi Linh Nguyen, Ji Sun Moon, Hyo Ju Jang, Jung-Mo Hwang, Hyon-Seung Yi Endocrinology and Metabolism.2024; 39(3): 521. CrossRef
Determinants of bone mass in older adults with normal- and overweight derived from the crosstalk with muscle and adipose tissue Carina O. Walowski, Catrin Herpich, Janna Enderle, Wiebke Braun, Marcus Both, Mario Hasler, Manfred J. Müller, Kristina Norman, Anja Bosy-Westphal Scientific Reports.2023;[Epub] CrossRef
Role of the Osteocyte in Musculoskeletal Disease Anika Shimonty, Lynda F. Bonewald, Fabrizio Pin Current Osteoporosis Reports.2023; 21(3): 303. CrossRef
The role of sclerostin in lipid and glucose metabolism disorders Hewen Jiang, Dijie Li, Ying Han, Nanxi Li, Xiaohui Tao, Jin Liu, Zongkang Zhang, Yuanyuan Yu, Luyao Wang, Sifan Yu, Ning Zhang, Huan Xiao, Xin Yang, Yihao Zhang, Ge Zhang, Bao-Ting Zhang Biochemical Pharmacology.2023; 215: 115694. CrossRef
Cytokines and exosomal miRNAs in skeletal muscle–adipose crosstalk Liu Guo, Menchus Quan, Weijun Pang, Yulong Yin, Fengna Li Trends in Endocrinology & Metabolism.2023; 34(10): 666. CrossRef
Sclerostin: clinical insights in muscle–bone crosstalk Antimo Moretti, Giovanni Iolascon Journal of International Medical Research.2023;[Epub] CrossRef
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment Giovanni Iolascon, Sara Liguori, Marco Paoletta, Giuseppe Toro, Antimo Moretti Therapeutic Advances in Musculoskeletal Disease.2023;[Epub] CrossRef
Sclerostin as a Putative Myokine in Sarcopenia Hyon-Seung Yi Endocrinology and Metabolism.2022; 37(3): 430. CrossRef
Organokines, Sarcopenia, and Metabolic Repercussions: The Vicious Cycle and the Interplay with Exercise Giulia Minniti, Letícia Maria Pescinini-Salzedas, Guilherme Almeida dos Santos Minniti, Lucas Fornari Laurindo, Sandra Maria Barbalho, Renata Vargas Sinatora, Lance Alan Sloan, Rafael Santos de Argollo Haber, Adriano Cressoni Araújo, Karina Quesada, Jesse International Journal of Molecular Sciences.2022; 23(21): 13452. CrossRef
Background Homocysteine has been drawing attention with a closed linkage with skeletal muscle. However, the association of hyperhomocysteinemia with decreased skeletal muscle mass remains unclear. We aimed to investigate the association of hyperhomocysteinemia with low skeletal muscle mass (LMM) in asymptomatic adults.
Methods This was a cross-sectional study of 114,583 community-dwelling adults without cancer, stroke, or cardiovascular diseases who underwent measurements of plasma homocysteine and body composition analysis from 2012 to 2018. Hyperhomocysteinemia was defined as >15 μmol/L. Skeletal muscle mass index (SMI) was calculated based on appendicular muscle mass (kg)/height (m)2. Participants were classified into three groups based on SMI: “normal,” “mildly low,” and “severely low.”
Results The prevalence of hyperhomocysteinemia was the highest in subjects with severely LMM (12.9%), followed by those with mildly LMM (9.8%), and those with normal muscle mass (8.5%) (P for trend <0.001). In a multivariable logistic regression model, hyperhomocysteinemia was significantly associated with having a mildly LMM (odds ratio [OR], 1.305; 95% confidence interval [CI], 1.224 to 1.392) and severely LMM (OR, 1.958; 95% CI, 1.667 to 2.286), respectively. One unit increment of log-transformed homocysteine was associated with 1.360 and 2.169 times higher risk of having mildly LMM and severely LMM, respectively.
Conclusion We demonstrated that elevated homocysteine has an independent association with LMM in asymptomatic adults, supporting that hyperhomocysteinemia itself can be a risk for decline in skeletal musculature.
Citations
Citations to this article as recorded by
The role of the mitochondrial trans-sulfuration in cerebro-cardio renal dysfunction during trisomy down syndrome Sathnur Pushpakumar, Mahavir Singh, Utpal Sen, N. Tyagi, Suresh C. Tyagi Molecular and Cellular Biochemistry.2024; 479(4): 825. CrossRef
Association of vitamins B1 and B2 intake with early-onset sarcopenia in the general adult population of the US: a cross-sectional study of NHANES data from 2011 to 2018 Sha Yang, Zhenyu Dong, Jiaqi Zhao, Lijia Yuan, Yao Xiao, Xing Luo, Zhuyang Zhao, Xia Kang, Kanglai Tang, Ming Chen, Liu Feng Frontiers in Nutrition.2024;[Epub] CrossRef
Differences in Type 2 Fiber Composition in the Vastus Lateralis and Gluteus Maximus of Patients with Hip Fractures Jingwen Tian, Minchul Song, Kyu Jeong Cho, Ho Yeop Lee, Sang Hyeon Ju, Jung Ryul Lim, Ha Thi Nga, Thi Linh Nguyen, Ji Sun Moon, Hyo Ju Jang, Jung-Mo Hwang, Hyon-Seung Yi Endocrinology and Metabolism.2024; 39(3): 521. CrossRef
Impact of Hyperhomocysteinemia on Cytokine and Matrix Metalloproteinases Contents in Rat Skeletal Muscle Olha Kravchenko, Raksha Nataliia, Kostiuk Oleksandra, Liashevska Oleksandra, Tiron Oksana, Maievskyi Oleksandr Biomedical and Biotechnology Research Journal.2024; 8(3): 387. CrossRef
The Relevance of Plant-Based Diets and Micronutrient Supplementation for Body Composition: Data from the VeggieNutri Cross-Sectional Study Cátia Pinheiro, Flávia Silva, Inês Rocha, Carina Martins, Liliana Giesteira, Bruna Dias, Ana Lucas, Ana Margarida Alexandre, Catarina Ferreira, Bruna Viegas, Isabella Bracchi, Juliana Guimarães, Joana Amaro, Teresa F. Amaral, Cláudia Camila Dias, Andreia Nutrients.2024; 16(19): 3322. CrossRef
The unique presentation of the relationship between red blood cell folate and appendicular skeletal muscle mass: a cross-sectional study Liangchuan Zhang, Yating Peng, Yuan Kong, Xue Zhang, Zetian Li, Hong Jia Scientific Reports.2024;[Epub] CrossRef
Association of Triglyceride-Glucose Index with the Risk of Hyperhomocysteinemia Among Chinese Male Bus Drivers: A Longitudinal Study Juan Xiong, Yanxia Wu, Lingling Huang, Xujuan Zheng International Journal of General Medicine.2023; Volume 16: 2857. CrossRef
Relationship between hyperhomocysteinemia and coexisting obesity with low skeletal muscle mass in asymptomatic adult population Tae Kyung Yoo, Hye Chang Rhim, Yong-Taek Lee, Kyung Jae Yoon, Chul-Hyun Park Scientific Reports.2022;[Epub] CrossRef
Causal effects of homocysteine levels on the components of sarcopenia: A two-sample mendelian randomization study Hongwei Yu, Gan Luo, Tianwei Sun, Qiong Tang Frontiers in Genetics.2022;[Epub] CrossRef
Association between serum homocysteine and sarcopenia among hospitalized older Chinese adults: a cross-sectional study Bing Lu, Lingyu Shen, Haiqiong Zhu, Ling Xi, Wei Wang, Xiaojun Ouyang BMC Geriatrics.2022;[Epub] CrossRef
Background The efficacy and safety of denosumab have been established in a phase 3, randomized, placebo-controlled trial in Korean postmenopausal women with osteoporosis. This postmarketing surveillance study was aimed to investigate the safety and effectiveness of denosumab in Korean real-world clinical practice.
Methods Patients with osteoporosis who had received denosumab per the Korean approved indications in the postmarketing setting between September 2014 and September 2019 were enrolled. The primary endpoint was the incidence of adverse events (AEs) and adverse drug reactions (ADRs). The secondary endpoint was the percent change from baseline in bone mineral density (BMD) of the lumbar spine, total hip, and femoral neck.
Results Of the 3,221 patients enrolled, 3,185 were included in the safety analysis set; 2,973 (93.3%) were female, and the mean± standard deviation (SD) age was 68.9±9.9 years. The mean±SD study period was 350.0±71.4 days. AEs, fatal AEs, and ADRs occurred in 19.3%, 0.8%, and 1.6%, respectively. The most frequent AEs, occurring in >0.5% of patients, were dizziness (0.7%), arthralgia (0.7%), back pain (0.6%), and myalgia (0.6%). Hypocalcemia occurred in 0.3% of patients. There were no cases of osteonecrosis of the jaw and atypical femoral fracture. Mean±SD percent change from baseline in BMD of the lumbar spine, total hip, and femoral neck was 7.3%±23.6%, 3.6%±31.4%, and 3.2%±10.7%, respectively.
Conclusion The safety and effectiveness of denosumab in Korean patients with osteoporosis in this study were comparable with those in the Korean randomized controlled trial, with no new safety findings.
Citations
Citations to this article as recorded by
Prevalence of denosumab-induced hypocalcemia: a retrospective observational study of patients routinely monitored with ionized calcium post-injection Anna Spångeus, Johan Rydetun, Mischa Woisetschläger Osteoporosis International.2024; 35(1): 173. CrossRef
Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea Seungju Cha, Minjeong Sohn, Hyowon Yang, Eric J. Yeh, Ki-Hyun Baek, Jeonghoon Ha, Hyemin Ku BMC Musculoskeletal Disorders.2024;[Epub] CrossRef
Denosumab and the Risk of Diabetes in Patients Treated for Osteoporosis Huei-Kai Huang, Albert Tzu-Ming Chuang, Tzu-Chi Liao, Shih-Chieh Shao, Peter Pin-Sung Liu, Yu-Kang Tu, Edward Chia-Cheng Lai JAMA Network Open.2024; 7(2): e2354734. CrossRef
A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab Yue He, Rong Zhang, Huarui Shen, Yingqi Liu Frontiers in Pharmacology.2024;[Epub] CrossRef
Denosumab in Osteoporosis: Predicting Long-Term Efficacy beyond 10 Years Jeongmin Lee, Youn-Ju Lee, Jeonghoon Ha Journal of Bone Metabolism.2024; 31(3): 246. CrossRef
Adverse Effects of Denosumab in Kidney Transplant Recipients: A 20-Year Retrospective Single-Center Observation Study in Central Taiwan Tsung-Yin Tsai, Zi-Hong You, Shang-Feng Tsai, Ming-Ju Wu, Tung-Min Yu, Ya-Wen Chuang, Yung-Chieh Lin, Ya-Lian Deng, Chiann-Yi Hsu, Cheng-Hsu Chen Transplantation Proceedings.2023; 55(4): 837. CrossRef
Persistence with Denosumab in Male Osteoporosis Patients: A Real-World, Non-Interventional Multicenter Study Chaiho Jeong, Jeongmin Lee, Jinyoung Kim, Jeonghoon Ha, Kwanhoon Jo, Yejee Lim, Mee Kyoung Kim, Hyuk-Sang Kwon, Tae-Seo Sohn, Ki-Ho Song, Moo Il Kang, Ki-Hyun Baek Endocrinology and Metabolism.2023; 38(2): 260. CrossRef
Effect of Denosumab on Bone Density in Postmenopausal Osteoporosis: A Comparison with and without Calcium Supplementation in Patients on Standard Diets in Korea Chaiho Jeong, Jinyoung Kim, Jeongmin Lee, Yejee Lim, Dong-Jun Lim, Ki-Hyun Baek, Jeonghoon Ha Journal of Clinical Medicine.2023; 12(21): 6904. CrossRef
Vitamin D has received considerable optimistic attention as a potentially important factor in many pathological states over the past few decades. However, the proportion of the active form of vitamin D metabolites responsible for biological activity is highly questionable in disease states due to flexible alterations in the enzymes responsible for their metabolism. For instance, CYP3A4 plays a crucial role in the biotransformation of vitamin D and other drug substances. Food-drug and/or drug-drug interactions, the disease state, genetic polymorphism, age, sex, diet, and environmental factors all influence CYP3A4 activity. Genetic polymorphisms in CYP450-encoding genes have received considerable attention in the past few decades due to their extensive impact on the pharmacokinetic and dynamic properties of drugs and endogenous substances. In this review, we focused on CYP3A4 polymorphisms and their interplay with vitamin D metabolism and summarized the role of vitamin D in calcium homeostasis, bone diseases, diabetes, cancer, other diseases, and drug substances. We also reviewed clinical observations pertaining to CYP3A4 polymorphisms among the aforementioned disease conditions. In addition, we highlighted the future perspectives of studying the pharmacogenetics of CYP3A4, which may have potential clinical significance for developing novel diagnostic genetic markers that will ascertain disease risk and progression.
Citations
Citations to this article as recorded by
Revealing the association between vitamin D metabolic pathway gene variants and lung cancer risk: a systematic review and meta-analysis Mohamed I. Elsalahaty, Samar Sami Alkafaas, Aya O. Bashir, Khaled A. El-Tarabily, Mohamed T. El-Saadony, Eman H. Yousef Frontiers in Genetics.2024;[Epub] CrossRef
Vitamin D in Melanoma: Potential Role of Cytochrome P450 Enzymes Mohamed Ben-Eltriki, Erysa J. Gayle, Jhoanne M. Paras, Louisa Nyame-Addo, Manik Chhabra, Subrata Deb Life.2024; 14(4): 510. CrossRef
Explore the mechanism of Astragalus membranaceus and Poria cocos drug pair in improving immunity based on network pharmacology Yuting Bai, Na Ning, Jianjun Zhao, Guoqing Chen, Yuhua Du, Shicong Huang, Xilong Jiang, Xuelan Feng, Yuanyuan Feng, Yi Nan, Ling Yuan Medicine.2024; 103(25): e38531. CrossRef
Imiglucerase, cholecalciferol, and bone-diet in skeletal health management of type I Gaucher disease patients: a pilot study and systematic review Antonio Barbato, Anita Vergatti, Alfonso Giaquinto, Ilaria Libera Pizzulo, Ludovica Perna, Giuseppe Perruolo, Veronica Abate, Michelina Sibilio, Ciro Mainolfi, Ernesto Soscia, Gianpaolo De Filippo, Pietro Formisano, Ferruccio Galletti, Pasquale Strazzullo JBMR Plus.2024;[Epub] CrossRef
Heat stress as a potential risk factor for vitamin D deficiency Martina Balducci, Letizia Pruccoli, Andrea Tarozzi Medical Hypotheses.2023; 176: 111085. CrossRef
Association and Haplotype Analysis of the PON1, ITGB3 and CYP3A4 Genes, Strong Candidates for Familial Coronary Artery Disease Susceptibility Faruk SAYDAM, İrfan DEĞİRMENCİ, Alparslan BİRDANE, Cansu ÖZBAYER, Taner ULUS, Mahmut ÖZDEMİR, Necmi ATA, Hasan Veysi GÜNEŞ Online Türk Sağlık Bilimleri Dergisi.2023; 8(1): 81. CrossRef
Association of flame retardants, polybrominated diethyl ethers (PBDEs), with vitamin D in female subjects Alexandra E. Butler, Edwina Brennan, Daniel S. Drage, Thozhukat Sathyapalan, Stephen L. Atkin Chemosphere.2023; 338: 139488. CrossRef
Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro Sai-li Xie, Xiayan Zhu, Nanyong Gao, Qianmeng Lin, Chaojie Chen, Yun-jun Yang, Jian-ping Cai, Guo-xin Hu, Ren-ai Xu Food and Chemical Toxicology.2023; 181: 114101. CrossRef
Caloric restriction (CR) is now a popular lifestyle choice due to its ability in experimental animals to improve lifespan, reduce body weight, and lessen oxidative stress. However, more and more emerging evidence suggests this treatment requires careful consideration because of its detrimental effects on the skeletal system. Experimental and clinical studies show that CR can suppress bone growth and raise the risk of fracture, but the specific mechanisms are poorly understood. Reduced mechanical loading has long been thought to be the primary cause of weight loss-induced bone loss from calorie restriction. Despite fat loss in peripheral depots with calorie restriction, bone marrow adipose tissue (BMAT) increases, and this may play a significant role in this pathological process. Here, we update recent advances in our understanding of the effects of CR on the skeleton, the possible pathogenic role of BMAT in CR-induced bone loss, and some strategies to mitigate any potential side effects on the skeletal system.
Citations
Citations to this article as recorded by
Strategies for minimizing muscle loss during use of incretin‐mimetic drugs for treatment of obesity Jeffrey I. Mechanick, W. Scott Butsch, Sandra M. Christensen, Osama Hamdy, Zhaoping Li, Carla M. Prado, Steven B. Heymsfield Obesity Reviews.2025;[Epub] CrossRef
Calorie restriction induces mandible bone loss by regulating mitochondrial function Linyi Liu, Phuong T. Le, Victoria E. DeMambro, Tiange Feng, Hanghang Liu, Wangyang Ying, Roland Baron, Clifford J. Rosen Bone.2025; 190: 117326. CrossRef
Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health Gregório Corrêa Guimarães, João Bosco Costa Coelho, João Gabriel Oliveira Silva, Ana Carolina Chalfun de Sant’Ana, Cássia Alves Carrilho de Sá, Júlia Marques Moreno, Lívia Marçal Reis, Camila Souza de Oliveira Guimarães Osteoporosis International.2024; 35(4): 575. CrossRef
Bone Marrow Adipose Tissue Is Not Required for Reconstitution of the Immune System Following Irradiation in Male Mice Jessica A. Keune, Carmen P. Wong, Adam J. Branscum, Scott A. Menn, Urszula T. Iwaniec, Russell T. Turner International Journal of Molecular Sciences.2024; 25(4): 1980. CrossRef
Dietary restriction plus exercise change gene expression of Cxcl12 abundant reticular cells in female mice Aoi Ikedo, Yuuki Imai Journal of Bone and Mineral Metabolism.2024; 42(3): 271. CrossRef
Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial Morten S. Hansen, Eva M. Wölfel, Shakespeare Jeromdesella, Jens-Jakob K. Møller, Charlotte Ejersted, Niklas R. Jørgensen, Richard Eastell, Stinus G. Hansen, Morten Frost eClinicalMedicine.2024; 72: 102624. CrossRef
Calorie restriction in mice impairs cortical but not trabecular peak bone mass by suppressing bone remodeling Linyi Liu, Phuong T Le, J Patrizia Stohn, Hanghang Liu, Wangyang Ying, Roland Baron, Clifford J Rosen Journal of Bone and Mineral Research.2024;[Epub] CrossRef
Connecting bone metastasis, adipose tissue and adipokines: How does physical activity fit? Paola Maroni, Marta Gomarasca, Michela Signo, Giovanni Lombardi Advanced Exercise and Health Science.2024; 1(3): 149. CrossRef